- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Progressive familial intrahepatic cholestasis (PFIC)
- Meeting Date: July 2024
- Public Summary Document (PSD) July 2024 PBAC Meeting - (PDF 1.3MB)
- Public Summary Document (PSD) July 2024 PBAC Meeting - (Word 573KB)
Odevixibat – July 2024
Odevixibat; Capsule 200 micrograms, Capsule 400 micrograms, Capsule 600 micrograms, Capsule 1200 micrograms; Bylvay®
Last updated
30 May 2025